Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報

【英語タイトル】Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(DATA904C4474)・商品コード:DATA904C4474
・発行会社(調査会社):MarketLine
・発行日:2018年8月
・ページ数:49
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Acorda Therapeutics (Acorda or ‘the company’) is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Acorda Therapeutics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Acorda Therapeutics, Inc.: Company Overview 9
Acorda Therapeutics, Inc.: Overview and Key Facts 9
Acorda Therapeutics, Inc.: Overview 9
Acorda Therapeutics, Inc.: Key Facts 9
Acorda Therapeutics, Inc.: Key Employees 11
Acorda Therapeutics, Inc.: Key Employee Biographies 12
Acorda Therapeutics, Inc.: Major Products and Services 19
Acorda Therapeutics, Inc.: Company History 20
Acorda Therapeutics, Inc.: Management Statement 23
Acorda Therapeutics, Inc.: Locations and Subsidiaries 25
Acorda Therapeutics, Inc.: Key Competitors 26
Acorda Therapeutics, Inc.: Company Analysis 27
Acorda Therapeutics, Inc.: Business Description 27
Acorda Therapeutics, Inc.: SWOT Analysis 28
Acorda Therapeutics, Inc.: SWOT Overview 28
Acorda Therapeutics, Inc.: Strengths 28
Acorda Therapeutics, Inc.: Weaknesses 29
Acorda Therapeutics, Inc.: Opportunities 29
Acorda Therapeutics, Inc.: Threats 30
Acorda Therapeutics, Inc.: Corporate Financial Deals Activity 32
Acorda Therapeutics, Inc.: Financial Deals Overview 32
Acorda Therapeutics, Inc.: Targets and Partners 34
Acorda Therapeutics, Inc.: Top Deals 2014 – 2018YTD* 35
Acorda Therapeutics, Inc.: Advisors 36
Acorda Therapeutics, Inc.: Top Legal Advisors 36
Acorda Therapeutics, Inc.: Top Financial Advisors 36
Acorda Therapeutics, Inc.: Mergers and Acquisitions 37
Acorda Therapeutics, Inc.: Private Equity and Ownership 38
Acorda Therapeutics, Inc.: Recent Developments 39
Acorda Therapeutics, Inc.: News and Events Summary 39
Acorda Therapeutics, Inc.: Corporate Governance 42
Acorda Therapeutics, Inc.: Financial Performance 42
Acorda Therapeutics, Inc.: Market Developments 43
Acorda Therapeutics, Inc.: Red Flags/DistressSignals 44
Acorda Therapeutics, Inc.: Research & Development 44
Acorda Therapeutics, Inc.: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Acorda Therapeutics, Inc.: Key Facts
Table 2: Acorda Therapeutics, Inc.: Key Employees
Table 3: Acorda Therapeutics, Inc.: Locations and Subsidiaries
Table 4: Acorda Therapeutics, Inc.: Key Competitors
Table 5: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Acorda Therapeutics, Inc.: Targets and Partners
Table 9: Acorda Therapeutics, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 16: Acorda Therapeutics, Inc.: News and Events Summary
Table 17: Acorda Therapeutics, Inc.: Corporate Governance
Table 18: Acorda Therapeutics, Inc.: Financial Performance
Table 19: Acorda Therapeutics, Inc.: Market Developments
Table 20: Acorda Therapeutics, Inc.: Red Flags/DistressSignals
Table 21: Acorda Therapeutics, Inc.: Research & Development
Table 22: Acorda Therapeutics, Inc.: Strategy and Operations

List of Figures
Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★調査レポート[Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報] (コード:DATA904C4474)販売に関する免責事項を必ずご確認ください。
★調査レポート[Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆